Tracks nutrition and lifestyle in children with leukemia or brain tumors
Observes nutrition, lifestyle and quality of life in children with leukemia or brain tumors.
Key facts
- Who runs it
- Columbia University
- Where
- New York, United StatesSee the site
- Trial code
- Registry title
- European Prospective Investigation Into Childhood Cancer
- Status
- Recruiting
- People taking part
- 1,400 people, planned
- Started
- 7 Jul 2023
- Expected to end
- 1 Mar 2031
- Type of study
- Observational, 2 groups
- Treatments tested
- Observational
- Record updated
- 2 June 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for children and young people aged 3 to 21 with newly diagnosed acute lymphoblastic leukemia (ALL) or a favorable biology brain tumor, treated at a participating center in Spain, Greece or Italy. It studies nutrition during treatment.
- Age
- 3 to 21 years at the time of consent.
- Sex
- All sexes can join.
- Disease stage
- Newly diagnosed B-cell ALL, T-cell ALL or mixed phenotype acute leukemia. Or a newly diagnosed favorable biology brain tumor, such as low-grade glioma, medulloblastoma, ependymoma, pituitary tumor or germ cell tumor.
- Earlier treatment
- Consent must come within three working days of an ALL diagnosis. For brain tumors, consent must come before chemotherapy, radiation or stem cell transplant starts. Patients receive standard treatment.
- Biomarker or test result
- ALL must be confirmed by immunophenotyping by flow cytometry. Brain tumors are confirmed by pathology report, imaging and/or biochemical studies.
Main reasons for not taking part
- Relapsed or progressive disease (except unresectable low-grade gliomas with progression)
- History of another primary cancer
- Other conditions that may affect nutrition or growth, such as Down's syndrome, metabolic disorders or celiac disease
- ALL: plans for a hematopoietic stem cell transplant
- Brain tumors managed by observation or surgery only, or ATRT or high-grade gliomas
The registry criteria, word for word
Show all 15 criteriaShow less
Who can take part
- Age: ALL and favorable biology brain tumors: Patient must be between 3 years and 21 years of age at the time of consent
- Diagnosis:
- ALL: Patients must have newly diagnosed B-cell ALL, T-cell ALL, or mixed phenotype acute leukemia confirmed by immunophenotyping by flow cytometry
- Brain tumors: Patients must have newly diagnosed favorable biology brain tumor confirmed by either pathology report, imaging and/or biochemical studies including low-grade gliomas, medulloblastoma, ependymoma, pituitary tumors, germ cell tumors; Treatment:
- ALL and brain tumors: Participants may be children on a clinical trial or "as per" a clinical trial
- ALL: Patients will receive standard leukemia treatment
- Brain tumors: Patients will be treated depending upon standard approach with surgery, chemotherapy, radiation therapy. Patients receiving autologous stem cell transplantation as part of their regimen may be included; Location: ALL and brain tumors: Patients must be receiving treatment at one of the participating centers; Timing:
- ALL: Parents/guardians must consent and patient assent, if applicable, within three working days of diagnosis
- Brain tumors: Parents/guardians must consent and assent, if applicable, prior to initiation of chemotherapy, radiation or stem cell transplant
Who cannot take part
- Patient plans to receive hematopoietic stem cell transplant
- Mixed lineage leukemias who receive AML-based protocols. Brain tumors: Children/adolescents who will be managed by observation or surgery only, or diagnosed with ATRT or high-grade gliomas
- Patients with relapsed or progressive disease, exclusive of patients with unresectable low-grade gliomas who have progressive disease
- Patients with history of other primary malignancy
- Patients with other medical conditions not associated with the malignancy that may interfere with nutritional status/growth and/or microbiome composition, like patients with Down's syndrome, metabolic disorders or celiac disease. Patients with genetic predisposition that may interfere with nutritional status/growth; ALL:
- ALL and brain tumors:
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 3 and 21 years old?
Where in United States
- Columbia University Irving Medical CenterNew York, United StatesContact: Michelle WaltersTaking people
About the trial
What the trial wants to find out
Over the last decades, research has shown that poor nutritional status can adversely impact prognosis and increase toxicities during treatment for childhood cancer. EPICkids is a collaboration between the International Initiative for Pediatrics and Nutrition, the International Agency for Research on Cancer, and sites throughout three Southern European countries (Spain, Greece, and Italy). The primary aim of EPICkids is to establish an informational resource on critical nutrition parameters wherein we can describe the trajectory of nutritional status among Southern European children and adolescents with acute lymphoblastic leukemia (ALL) and favorable biology brain tumors, investigate lifestyle behaviors, sociodemographic factors, and quality of life and correlate these indicators with clinical outcomes. The specimens obtained with the proposed study will foster future studies on nutrition and prevalent childhood cancer as well as establish a framework to develop evidence-based guidelines for European children with cancer, utilizing regional, European data. We plan to recruit 900 patients with ALL and 1400 patients with a favorable biology brain tumor over five years. Nutrition parameters and lifestyle factors will be measured at systematic timepoints over the study period. Stool and blood specimens will be collected at each timepoint. Eligible patients will be between 3 and 21 years of age.
The 2 groups in the trial
- Acute lymphoblastic leukemia cohort
Treatment: Observational
- Brain tumor cohort
Treatment: Observational
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Southern European Prospective Investigation Into Childhood Cancer and Nutrition (EPICkids)
- Plain-language title
- Tracks nutrition and lifestyle in children with leukemia or brain tumorsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT05375617, who can take part
- Publications
- Record updated
- 2 June 2026